These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21063684)

  • 1. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.
    Lehmann ML; Selinski S; Blaszkewicz M; Orlich M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Beg AE; Aslam M; Bánfi G; Romics I; Ickstadt K; Schwender H; Winterpacht A; Hengstler JG; Golka K
    Arch Toxicol; 2010 Dec; 84(12):967-78. PubMed ID: 21063684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
    Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Lukas C; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2012 Feb; 86(2):195-203. PubMed ID: 21892705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
    Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common predisposition alleles for moderately common cancers: bladder cancer.
    Kiltie AE
    Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and chromosome 9 alterations in bladder cancer.
    Zhang ZF; Shu XM; Cordon-Cardo C; Orlow I; Lu ML; Millon TV; Cao PQ; Connolly-Jenks C; Dalbagni G; Lianes P; Lacombe L; Reuter VE; Scher H
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):321-6. PubMed ID: 9149891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study.
    Brockmöller J; Kerb R; Drakoulis N; Staffeldt B; Roots I
    Cancer Res; 1994 Aug; 54(15):4103-11. PubMed ID: 8033143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
    Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
    Broberg K; Björk J; Paulsson K; Höglund M; Albin M
    Carcinogenesis; 2005 Jul; 26(7):1263-71. PubMed ID: 15746160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
    Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
    Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere length, cigarette smoking, and bladder cancer risk in men and women.
    McGrath M; Wong JY; Michaud D; Hunter DJ; De Vivo I
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):815-9. PubMed ID: 17416776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
    Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
    Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.